268 related articles for article (PubMed ID: 25545445)
1. Nil-per-os days and necrotizing enterocolitis in extremely preterm infants.
Kirtsman M; Yoon EW; Ojah C; Cieslak Z; Lee SK; Shah PS
Am J Perinatol; 2015 Jul; 32(8):785-94. PubMed ID: 25545445
[TBL] [Abstract][Full Text] [Related]
2. Enteral feeding during indomethacin treatment for patent ductus arteriosus: association with gastrointestinal outcomes.
Louis D; Torgalkar R; Shah J; Shah PS; Jain A
J Perinatol; 2016 Jul; 36(7):544-8. PubMed ID: 26914015
[TBL] [Abstract][Full Text] [Related]
3. Probiotics for the prevention of necrotizing enterocolitis in neonates: an 8-year retrospective cohort study.
Li D; Rosito G; Slagle T
J Clin Pharm Ther; 2013 Dec; 38(6):445-9. PubMed ID: 23865733
[TBL] [Abstract][Full Text] [Related]
4. Prolonged persistent patent ductus arteriosus: potential perdurable anomalies in premature infants.
Saldeño YP; Favareto V; Mirpuri J
J Perinatol; 2012 Dec; 32(12):953-8. PubMed ID: 22460543
[TBL] [Abstract][Full Text] [Related]
5. Neonatal necrotizing enterocolitis with intestinal perforation in extremely premature infants receiving early indomethacin treatment for patent ductus arteriosus.
Fujii AM; Brown E; Mirochnick M; O'Brien S; Kaufman G
J Perinatol; 2002; 22(7):535-40. PubMed ID: 12368968
[TBL] [Abstract][Full Text] [Related]
6. Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin.
Grosfeld JL; Chaet M; Molinari F; Engle W; Engum SA; West KW; Rescorla FJ; Scherer LR
Ann Surg; 1996 Sep; 224(3):350-5; discussion 355-7. PubMed ID: 8813263
[TBL] [Abstract][Full Text] [Related]
7. Incidence and timing of presentation of necrotizing enterocolitis in preterm infants.
Yee WH; Soraisham AS; Shah VS; Aziz K; Yoon W; Lee SK;
Pediatrics; 2012 Feb; 129(2):e298-304. PubMed ID: 22271701
[TBL] [Abstract][Full Text] [Related]
8. Necrotizing enterocolitis and gastrointestinal complications after indomethacin therapy and surgical ligation in premature infants with patent ductus arteriosus.
O'Donovan DJ; Baetiong A; Adams K; Chen A; Smith EO; Adams JM; Weisman LE
J Perinatol; 2003 Jun; 23(4):286-90. PubMed ID: 12774134
[TBL] [Abstract][Full Text] [Related]
9. [Perinatal high-risk factors for necrotizing enterocolitis in preterm infants: a case-control study].
Wang RJ; Kong XY; Cai N; Chen Y; Feng ZC
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Apr; 16(4):414-7. PubMed ID: 24750842
[TBL] [Abstract][Full Text] [Related]
10. Treatment of patent ductus arteriosus and neonatal mortality/morbidities: adjustment for treatment selection bias.
Mirea L; Sankaran K; Seshia M; Ohlsson A; Allen AC; Aziz K; Lee SK; Shah PS;
J Pediatr; 2012 Oct; 161(4):689-94.e1. PubMed ID: 22703954
[TBL] [Abstract][Full Text] [Related]
11. Neonatal Intensive Care Unit-Level Patent Ductus Arteriosus Treatment Rates and Outcomes in Infants Born Extremely Preterm.
Isayama T; Kusuda S; Reichman B; Lee SK; Lehtonen L; Norman M; Adams M; Bassler D; Helenius K; Hakansson S; Yang J; Jain A; Shah PS;
J Pediatr; 2020 May; 220():34-39.e5. PubMed ID: 32145968
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic Interventions in Neonatology: How Do They Fare in Real Life?
Rolnitsky A; Lee SK; Piedbouf B; Harrison A; Shah PS;
Am J Perinatol; 2015 Oct; 32(12):1098-104. PubMed ID: 26171598
[TBL] [Abstract][Full Text] [Related]
13. [Clinical characteristics and risk factors for early-onset necrotizing enterocolitis in preterm infants with very/extremely low birth weight].
Yu ZY; Xu SJ; Sun HQ; Li MC; Xing S; Cheng P; Zhang HB; Wang YY; Yang ZJ
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Feb; 25(2):147-152. PubMed ID: 36854690
[TBL] [Abstract][Full Text] [Related]
14. Timing of pharmacological treatment for patent ductus arteriosus and risk of secondary surgery, death or bronchopulmonary dysplasia: a population-based cohort study of extremely preterm infants.
Gudmundsdottir A; Johansson S; Håkansson S; Norman M; Källen K; Bonamy AK
Neonatology; 2015; 107(2):87-92. PubMed ID: 25412681
[TBL] [Abstract][Full Text] [Related]
15. Does necrotising enterocolitis impact the neurodevelopmental and growth outcomes in preterm infants with birthweight < or =1250 g?
Soraisham AS; Amin HJ; Al-Hindi MY; Singhal N; Sauve RS
J Paediatr Child Health; 2006 Sep; 42(9):499-504. PubMed ID: 16925534
[TBL] [Abstract][Full Text] [Related]
16. Risk factors associated with necrotising enterocolitis in very low birth weight infants in Malaysian neonatal intensive care units.
Boo NY; Cheah IG
Singapore Med J; 2012 Dec; 53(12):826-31. PubMed ID: 23268157
[TBL] [Abstract][Full Text] [Related]
17. Intestinal perforation in very preterm neonates: risk factors and outcomes.
Shah J; Singhal N; da Silva O; Rouvinez-Bouali N; Seshia M; Lee SK; Shah PS;
J Perinatol; 2015 Aug; 35(8):595-600. PubMed ID: 25927271
[TBL] [Abstract][Full Text] [Related]
18. Comparison of oral ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants.
Fakhraee SH; Badiee Z; Mojtahedzadeh S; Kazemian M; Kelishadi R
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Oct; 9(5):399-403. PubMed ID: 17937843
[TBL] [Abstract][Full Text] [Related]
19. Relationship of neonatal treatments with the development of necrotizing enterocolitis in preterm infants.
Carter BM; Holditch-Davis D; Tanaka D; Schwartz TA
Nurs Res; 2012; 61(2):96-102. PubMed ID: 22282155
[TBL] [Abstract][Full Text] [Related]
20. Association Between Early Screening for Patent Ductus Arteriosus and In-Hospital Mortality Among Extremely Preterm Infants.
Rozé JC; Cambonie G; Marchand-Martin L; Gournay V; Durrmeyer X; Durox M; Storme L; Porcher R; Ancel PY;
JAMA; 2015 Jun 23-30; 313(24):2441-8. PubMed ID: 26103028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]